clomipramine (Q58713): Difference between revisions

From Wikidata

Jump to navigation Jump to search

Browse history interactively

← Older editNewer edit →

Revision as of 13:18, 6 December 2023 (restore) TiagoLubianaBot (talk | contribs) Bots 792,850 edits ‎Updated Item: Added drug-drug interaction. ← Older edit		Revision as of 13:18, 6 December 2023 (restore) undo TiagoLubianaBot (talk | contribs) Bots 792,850 edits ‎Updated Item: Added drug-drug interaction. Newer edit →
		Property / significant drug interaction
			enalapril
		Property / significant drug interaction: enalapril / rank
			Normal rank
		Property / significant drug interaction: enalapril / qualifier
			side effect: irritability
		Property / significant drug interaction: enalapril / reference
			sourcing circumstances: probably stated in: A reference set of clinically relevant adverse drug-drug interactions

---

Revision as of 13:18, 6 December 2023

chemical compound

• ANA586
• G-34586
• 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine
• 3-chloroimipramine
• chlorimipramine
• monochlorimipramine
• G 34586
• 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine

Language	Label	Description	Also known as
English	clomipramine	chemical compound	ANA586 G-34586 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine 3-chloroimipramine chlorimipramine monochlorimipramine G 34586 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine

Statements

instance of

type of chemical entity

0 references

subclass of

chemical compound

0 references

has use

medication

0 references

chemical structure

Clomipramine.svg
512 × 477; 7 KB

0 references

image of molecular model or crystal lattice model

Clomipramine-3D-balls.png
1,810 × 2,000; 526 KB

depicts

ball-and-stick model

0 references

mass

314.155 dalton

1 reference

stated in

PubChem

PubChem CID

2801

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

chemical formula

C₁₉H₂₃ClN₂

1 reference

stated in

PubChem

PubChem CID

2801

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

canonical SMILES

CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl

1 reference

stated in

PubChem

PubChem CID

2801

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

active ingredient in

Anafranil

1 reference

stated in

RxNorm

RxNorm ID

756

retrieved

14 February 2018

World Health Organisation international non-proprietary name

clomipramine (English)

IPA transcription

kloʊˈmɪpɹəmin

2 references

stated in

ChEMBL

ChEMBL ID

CHEMBL415

language of work or name

English

title

Clomipramine (English)

retrieved

19 January 2016

published in

Recommended INN: List 7

publication date

1967

medical condition treated

pain

1 reference

stated in

NDF-RT

NDF-RT ID

N0000147779

language of work or name

English

retrieved

13 December 2016

panic disorder

1 reference

stated in

NDF-RT

NDF-RT ID

N0000147779

language of work or name

English

retrieved

13 December 2016

neurotic disorder

1 reference

stated in

NDF-RT

NDF-RT ID

N0000147779

language of work or name

English

retrieved

13 December 2016

obsessive-compulsive disorder

2 references

stated in

NDF-RT

NDF-RT ID

N0000147779

language of work or name

English

retrieved

13 December 2016

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

obsessive-compulsive disorder

start time

29 December 1989

approved by

Food and Drug Administration

1 reference

stated in

Inxight: Drugs Database

retrieved

2 November 2018

reference URL

https://drugs.ncats.io/drug/NUV44L116D

http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019906s039lbl.pdf

significant drug interaction

isocarboxazid

1 reference

stated in

High-priority drug–drug interactions for use in electronic health records

phenelzine

1 reference

stated in

High-priority drug–drug interactions for use in electronic health records

procarbazine

1 reference

stated in

High-priority drug–drug interactions for use in electronic health records

(±)-deprenyl

1 reference

stated in

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

stated in

High-priority drug–drug interactions for use in electronic health records

disopyramide

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

droperidol

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

pimozide

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

loxapine

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

sotalol

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

lithium

side effect

long QT syndrome

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

side effect

hyponatremia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

hyponatremia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

side effect

hyponatremia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

side effect

hyponatremia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

sertraline

side effect

hyponatremia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

hyponatremia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

side effect

hyponatremia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

imipramine

side effect

hyponatremia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

side effect

hyponatremia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

naproxen

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

sulindac

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

side effect

hyponatremia

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

phenelzine

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

droperidol

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

pimozide

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

imipramine

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

enalapril

side effect

hypotension

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

propranolol

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

sotalol

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

clonidine

side effect

hypotension

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

clozapine

side effect

hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

lithium

side effect

toxic encephalopathy

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

side effect

torsades de pointes

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

side effect

pulseless electrical activity

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

side effect

cardiotoxicity

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

imipramine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

sotalol

side effect

torsades de pointes

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

clozapine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

pethidine

side effect

paralytic ileus

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

side effect

paralytic ileus

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

tramadol

side effect

paralytic ileus

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

side effect

paralytic ileus

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

phenelzine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

phenelzine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

phenelzine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

phenelzine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

linezolid

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

linezolid

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

linezolid

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

linezolid

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

moclobemide

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

moclobemide

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

moclobemide

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

moclobemide

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

naproxen

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

sulindac

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

side effect

retroperitoneal hemorrhage

1 reference

sourcing circumstances

established

stated in

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

side effect

heart arrhythmia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

side effect

hypertension

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

side effect

tachycardia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

side effect

heart arrhythmia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

side effect

hypertension

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

side effect

tachycardia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

propranolol

side effect

orthostatic hypotension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-nefopam

side effect

seizure

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

side effect

heart arrhythmia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

side effect

sedation

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

side effect

Delirium

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

bupropion

side effect

seizure

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

side effect

long QT syndrome

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

loxapine

side effect

cognitive disorder

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

loxapine

side effect

central respiratory depression

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

loxapine

side effect

sedation

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

loxapine

side effect

syncope

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

sedation

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

xerostomia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

urinary retention

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

side effect

torsades de pointes

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

side effect

pulseless electrical activity

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

side effect

paralytic ileus

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

enalapril

side effect

Sleep state misperception

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

enalapril

side effect

irritability

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Solute carrier family 6 member 3

subject has role

enzyme inhibitor

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2398

language of work or name

English

retrieved

17 August 2016

Potassium inwardly-rectifying channel, subfamily J, member 6

subject has role

enzyme inhibitor

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2398

language of work or name

English

retrieved

17 August 2016

Potassium inwardly-rectifying channel, subfamily J, member 5

subject has role

enzyme inhibitor

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2398

language of work or name

English

retrieved

17 August 2016

Solute carrier family 6 member 2

subject has role

enzyme inhibitor

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2398

language of work or name

English

retrieved

17 August 2016

solute carrier family 6 member 4

subject has role

enzyme inhibitor

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2398

language of work or name

English

retrieved

17 August 2016

pregnancy category

Australian pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

stated in

LiverTox

retrieved

8 April 2021

reference URL

https://www.ncbi.nlm.nih.gov/books/n/livertox/Clomipramine

last update

15 October 2017

subject has role

selective serotonin reuptake inhibitor

2 references

stated in

NDF-RT

NDF-RT ID

N0000147779

retrieved

5 March 2018

stated in

Medical Subject Headings

MeSH descriptor ID

D002997

retrieved

15 March 2018

adrenergic uptake inhibitors

1 reference

stated in

NDF-RT

NDF-RT ID

N0000147779

retrieved

5 March 2018

tricyclic antidepressant

1 reference

stated in

Medical Subject Headings

MeSH descriptor ID

D002997

retrieved

15 March 2018

essential medicine

0 references

stylized name

clomiPRAMINE

has characteristic

Tall Man lettering

issued by

Food and Drug Administration

subject named as

Clomipramine

1 reference

reference URL

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

retrieved

2 September 2022

Commons category

Clomipramine

0 references

Identifiers

InChI

InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3

1 reference

stated in

PubChem

PubChem CID

2801

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

InChIKey

GDLIGKIOYRNHDA-UHFFFAOYSA-N

2 references

stated in

PubChem

PubChem CID

2801

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

stated in

ChEBI release 2020-09-01

CAS Registry Number

303-49-1

2 references

stated in

Global Substance Registration System

UNII

NUV44L116D

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

InChIKey

GDLIGKIOYRNHDA-UHFFFAOYSA-N

stated in

CAS Common Chemistry

retrieved

10 April 2021

reference URL

https://commonchemistry.cas.org/detail?cas_rn=303-49-1

ChemSpider ID

2699

1 reference

stated in

ChemSpider

ChemSpider ID

2699

language of work or name

English

title

Clomipramine (English)

retrieved

17 November 2016

PubChem CID

2801

1 reference

stated in

PubChem

PubChem CID

2801

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

Reaxys registry number

1323477

1 reference

stated in

ChEBI

ChEBI ID

47780

language of work or name

English

title

clomipramine (English)

retrieved

19 October 2016

ChEBI ID

47780

mapping relation type

exact match

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL415

language of work or name

English

title

CLOMIPRAMINE (English)

retrieved

17 November 2016

ChEMBL ID

CHEMBL415

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL415

language of work or name

English

title

CLOMIPRAMINE (English)

retrieved

17 November 2016

UniChem compound ID

278551

1 reference

stated in

UniChem

MassBank accession ID

MSBNK-Athens_Univ-AU152706

0 references

MSBNK-Eawag-EQ366901

0 references

MSBNK-Eawag-EQ366902

0 references

MSBNK-Eawag-EQ366903

0 references

MSBNK-Eawag-EQ366904

0 references

MSBNK-Eawag-EQ366905

0 references

MSBNK-Eawag-EQ366906

0 references

MSBNK-Eawag-EQ366907

0 references

MSBNK-Eawag-EQ366908

0 references

MSBNK-Eawag-EQ366909

0 references

MSBNK-Waters-WA000980

0 references

MSBNK-Waters-WA000981

0 references

MSBNK-Waters-WA000982

0 references

MSBNK-Waters-WA000983

0 references

MSBNK-Waters-WA000984

0 references

SPLASH

splash10-014i-2009000000-a1cc70dad4bb4c19ab7b

0 references

splash10-000i-9000000000-a9af3369f8d6da434fd0

0 references

splash10-052r-9000000000-3f1941447bc096ea9d73

0 references

splash10-0a4r-9010000000-c6b5c5a56ac456cd8845

0 references

splash10-0a4i-9010000000-8b5307526ea875a06881

0 references

splash10-0a4i-9010000000-98746d4db184914ce871

0 references

splash10-0a4i-9310000000-194486cca11709cd1b80

0 references

splash10-0a4i-9600000000-da861dd5252aaff30e89

0 references

splash10-0a4i-6900000000-efdead8e50e8b700d4bd

0 references

splash10-00di-0090000000-c95496c45b925520559b

0 references

splash10-00di-0090000000-0f4826359eaf958cf3f9

0 references

splash10-014i-0009002000-5d404f398b1424000228

0 references

splash10-014i-0009000000-ee8c700208fb6d810d7f

0 references

splash10-066r-6391000000-e57dc447a97807ce527a

0 references

HSDB ID

7746

1 reference

stated in

Hazardous Substances Data Bank

HSDB ID

7746

publication date

28 October 2019

title

Clomipramine (English)

retrieved

10 May 2021

DSSTox substance ID

DTXSID6022844

1 reference

stated in

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

DTXCID602844

0 references

LiverTox ID

Clomipramine

0 references

NSC number

169865

0 references

EC number

206-144-2

1 reference

stated in

Global Substance Registration System

UNII

NUV44L116D

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

ECHA Substance Infocard ID

100.005.587

1 reference

stated in

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.005.587

retrieved

27 December 2018

title

Clomipramine (English)

quotation

CAS no.: 303-49-1 (English)

ATC code

N06AA04

1 reference

stated in

DrugBank

DrugBank ID

01242

language of work or name

English

title

Clomipramine (English)

publication date

17 November 2015

World Health Organisation international non-proprietary name numeric ID

2238

1 reference

reference URL

https://mednet-communities.net/inn/db/ViewINN.aspx?i=2238

Guide to Pharmacology Ligand ID

2398

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2398

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

MeSH descriptor ID

D002997

0 references

MeSH concept ID

M0004598

0 references

RxNorm ID

2597

1 reference

stated in

Global Substance Registration System

UNII

NUV44L116D

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

DrugBank ID

01242

1 reference

stated in

DrugBank

DrugBank ID

01242

language of work or name

English

title

Clomipramine (English)

retrieved

17 November 2016

UNII

NUV44L116D

1 reference

stated in

Global Substance Registration System

UNII

NUV44L116D

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

MedlinePlus drug identifier

a697002

0 references

NDF-RT ID

N0000147779

1 reference

stated in

Global Substance Registration System

UNII

NUV44L116D

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

Probes And Drugs ID

PD009943

0 references

DrugCentral ID

701

1 reference

stated in

UniChem

KEGG ID

D07727

1 reference

stated in

ChEBI

ChEBI ID

47780

language of work or name

English

title

clomipramine (English)

retrieved

19 October 2016

PDB ligand ID

CXX

0 references

BBC Things ID

b093c05d-fe2d-4ec1-850d-f5a6056fbb9a

1 reference

stated in

BBC Things

electronic Essential Medicines List medicine ID

249

1 reference

reference URL

https://list.essentialmeds.org/medicines/249

title

eEML - Electronic Essential Medicines List (English)

retrieved

23 October 2021

Encyclopædia Britannica Online ID

science/clomipramine

subject named as

clomipramine

0 references

Freebase ID

/m/05f_p3

1 reference

stated in

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

2779305415

0 references

OpenAlex ID

C2779305415

1 reference

stated in

OpenAlex

retrieved

26 January 2022

reference URL

https://docs.openalex.org/download-snapshot/snapshot-data-format

PDB structure ID

2QEI

1 reference

stated in

Protein Data Bank

PDB structure ID

2QEI

language of work or name

English

title

2QEI (English)

retrieved

19 October 2016

2Q6H

1 reference

stated in

Protein Data Bank

PDB structure ID

2Q6H

language of work or name

English

title

2Q6H (English)

retrieved

19 October 2016

4MMA

1 reference

stated in

Protein Data Bank

PDB structure ID

4MMA

language of work or name

English

title

4MMA (English)

retrieved

19 October 2016

Römpp online ID

RD-03-02078

1 reference

imported from Wikimedia project

German Wikipedia

UMLS CUI

C0009010

1 reference

stated in

Global Substance Registration System

UNII

NUV44L116D

language of work or name

English

title

clomipramine (English)

retrieved

17 November 2016

UNSPSC Code

51141614

0 references

WikiProjectMed ID

Clomipramine

0 references

WordNet 3.1 Synset ID

03052307-n

1 reference

stated in

GF WordNet

 

Sitelinks

Wikipedia(32 entries)

• arwiki كلوميبرامين
• azbwiki کلومیپرامین
• cswiki Klomipramin
• cywiki Clomipramin
• dewiki Clomipramin
• elwiki Κλομιπραμίνη
• enwiki Clomipramine
• eswiki Clomipramina
• fawiki کلومیپرامین
• fiwiki Klomipramiini
• frwiki Clomipramine
• hewiki קלומיפראמין
• huwiki Klomipramin
• hywiki Քլոմիպրամին
• itwiki Clomipramina
• jawiki クロミプラミン
• kowiki 클로미프라민
• lawiki Clomipraminum
• nlwiki Clomipramine
• nowiki Klomipramin
• orwiki କ୍ଲୋମିପ୍ରାମିନ
• plwiki Klomipramina
• ptwiki Clomipramina
• rowiki Clomipramină
• ruwiki Кломипрамин
• shwiki Klomipramin
• srwiki Klomipramin
• svwiki Klomipramin
• trwiki Klomipramin
• ukwiki Кломіпрамін
• viwiki Clomipramine
• zhwiki 氯米帕明

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

• commonswiki Category:Clomipramine

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58713&oldid=2025165053"